Scott Lyons Pescatore
Chief Executive Officer at Recordati Orphan Drugs SAS
Profile
Scott Lyons Pescatore is currently the Managing Director at Recordati Orphan Drugs SAS since 2020 and also holds the position of Managing Director at Recordati Rare Diseases Germany GmbH.
Scott Lyons Pescatore active positions
| Companies | Position | Start |
|---|---|---|
Recordati Orphan Drugs SAS
 Recordati Orphan Drugs SAS Financial ConglomeratesFinance Part of CVC Capital Partners Plc, Recordati Orphan Drugs SAS is an investment holding French company. The company is based in Puteaux, France. The company was founded in 2007. Scott Lyons Pescatore has been the CEO of the company since 2020. | Chief Executive Officer | 23/06/2020 |
Recordati Rare Diseases Germany GmbH
 Recordati Rare Diseases Germany GmbH Medical DistributorsDistribution Services Recordati Rare Diseases Germany GmbH is a pharmaceutical wholesaler based in Germany. The German company's main focus is on distributing pharmaceutical products. | Chief Executive Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Recordati Orphan Drugs SAS
Recordati Orphan Drugs SAS Financial ConglomeratesFinance Part of CVC Capital Partners Plc, Recordati Orphan Drugs SAS is an investment holding French company. The company is based in Puteaux, France. The company was founded in 2007. Scott Lyons Pescatore has been the CEO of the company since 2020. | Finance |
Recordati Rare Diseases Germany GmbH
Recordati Rare Diseases Germany GmbH Medical DistributorsDistribution Services Recordati Rare Diseases Germany GmbH is a pharmaceutical wholesaler based in Germany. The German company's main focus is on distributing pharmaceutical products. | Distribution Services |
- Stock Market
- Insiders
- Scott Lyons Pescatore
